Pentraxin3 as a new biomarker of peritoneal injury and cardiovascular event in peritoneal daialysis patients.

Pentraxin3 as a new biomarker of peritoneal injury and cardiovascular event in peritoneal daialysis patients. - PTx3 as a new marker of periotneal injury and CV event in PD patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015454

Enrollment

100

Registered

2014-10-17

Start date

2015-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peritoneal dailysis patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: peritoneal dialysis patients(initiation and maintaied)

Exclusion criteria

Exclusion criteria: peritonitis within 6 manths severe cardiovascular disease sepsis

Design outcomes

Primary

Measure	Time frame
peritonael injury and cardiovascular event	—

Countries

Japan

Contacts

Public ContactHiroakiIo

Division of Nephrology, Department of internal medicine, Faculty of Juntendo University Nephrology

hiroaki@juntendo.ac.jp81-3-3813-3111

Outcome results